Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 0.50 MYR
Change Today +0.01 / 2.06%
Volume 6.7M
HOV On Other Exchanges
Symbol
Exchange
Kuala Lumpur
As of 4:59 AM 08/3/15 All times are local (Market data is delayed by at least 15 minutes).

hovid bhd (HOV) Snapshot

Open
0.49
Previous Close
0.49
Day High
0.50
Day Low
0.49
52 Week High
04/21/15 - 0.56
52 Week Low
12/16/14 - 0.32
Market Cap
387.6M
Average Volume 10 Days
9.0M
EPS TTM
0.03
Shares Outstanding
783.0M
EX-Date
03/10/15
P/E TM
17.9x
Dividend
0.01
Dividend Yield
2.02%
Current Stock Chart for HOVID BHD (HOV)

Related News

No related news articles were found.

hovid bhd (HOV) Related Businessweek News

No Related Businessweek News Found

hovid bhd (HOV) Details

Hovid Berhad manufactures and sells pharmaceutical and herbal products. The company offers ethical drugs; dietary supplements; and consumer products, such as disinfectants and cosmetics, as well as herbal tea and Tocovid SupraBio, a health supplement product. In addition, the company engages in establishing, maintaining, and operating laboratories and shops for carrying on chemical, physical, and other research and development activities in medicine, chemistry, industry, and other fields. Further, it is involved in trading of medical supplies, pharmaceutical products, and consumer products. The company operates in Asia, Africa, North and South America, Europe, and the Pacific Island. Hovid Berhad is based in Ipoh, Malaysia.

hovid bhd (HOV) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

hovid bhd (HOV) Key Developments

Hovid Berhad Announces Incorporation of Subsidiary Company in Singapore

The Board of Directors of Hovid Berhad announced that the company has on 14 July 2015 incorporated a subsidiary company in Singapore known as Hovid Pte. Ltd. It was incorporated on 14 July 2015 as a private company limited by shares with issued capital of SGD 1,000 comprising 1,000 ordinary shares of SGD 1/- each fully paid. The intended principal activity of Hovid Pte. Ltd. is that of Research and Development.

Hovid Berhad has Changed its Name to Attest Research Sdn Bhd

On July 01, 2015, Hovid Berhad changed its name to Attest Research Sdn Bhd.

Hovid Berhad Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2015

Hovid Berhad reported unaudited consolidated earnings results for the third quarter and nine months ended March 31, 2015. For the quarter, the company's revenue was MYR 48,653,000 compared to MYR 50,655,000 a year ago. The lower revenue was due to some shipments being postponed. Profit from operations was MYR 9,056,000 compared to MYR 8,952,000 a year ago. Profit before tax was MYR 7,474,000 compared to MYR 7,108,000 a year ago, mainly due to the gain on disposal of BPPL of MYR 1.365 million, and a higher foreign exchange gain arising from the stronger United States of America Dollar. Profit for the period was MYR 6,049,000 compared to MYR 5,246,000 a year ago. Profit attributable to owners of the company was MYR 6,030,000 compared to MYR 5,155,000 a year ago. Earnings per share attributable to owners of the company - diluted at nominal value were MYR 0.10 per share was 0.62 sen compared to 0.55 sen a year ago. For the year, the company's revenue was MYR 145,708,000 compared to MYR 135,498,000 a year ago, million due to improved productivity and increase in orders. Profit from operations was MYR 26,340,000 compared to MYR 23,165,000 a year ago. Profit before tax was MYR 21,178,000 compared to MYR 17,643,000 a year ago, mainly due to increase in sales, gain on disposal of BPPL and higher foreign exchange gain arising from the stronger USD. Profit for the period was MYR 16,293,000 compared to MYR 13,716,000 a year ago. Profit attributable to owners of the company was MYR 16,406,000 compared to MYR 13,387,000 a year ago. Earnings per share attributable to owners of the company - diluted at nominal value were MYR 0.10 per share was 1.68 sen compared to 1.46 sen a year ago. Net cash from operating activities was MYR 15,304,000 compared to MYR 12,763,000 a year ago. Acquisition of property, plant and equipment was MYR 15,265,000 compared to MYR 4,394,000 a year ago. Product development expenditure incurred was MYR 1,891,000 compared to MYR 1,898,000 a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HOV:MK 0.50 MYR +0.01

HOV Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for HOV.
View Industry Companies
 

Industry Analysis

HOV

Industry Average

Valuation HOV Industry Range
Price/Earnings 22.7x
Price/Sales 1.9x
Price/Book 2.2x
Price/Cash Flow 13.9x
TEV/Sales 1.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HOVID BHD, please visit www.hovid.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.